Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice
- 530 Downloads
Non-alcoholic fatty liver disease is highly associated with morbidity and mortality in population. Although studies have already demonstrated that the immune response plays a pivotal role in the development of non-alcoholic fatty liver disease, the comprehensive regulation is unclear. Therefore, present study was carried out to investigate the non-alcoholic fatty liver disease development under neutrophil depletion.
To achieve the aim of the study, C57BL/6 J mice were fed with high fat diet for 6 weeks before treated with neutrophil deplete antibody 1A8 or isotype control (200 μg/ mouse every week) for another 4 weeks.
Treated with 1A8 antibody, obese mice exhibited better whole body metabolic parameters, including reduction of body weight gain and fasting blood glucose levels. Neutrophil depletion also effectively reduced hepatic structural disorders, dysfunction and lipid accumulation. Lipid β-oxidative markers, phosphorylated-AMP-activated protein kinase α and phosphorylated-acetyl-CoA carboxylase levels were increased in 1A8 antibody-treated obese mouse group. The mitochondrial number and function were also reversed after 1A8 antibody treatment, including increased mitochondrial number, reduced lipid oxidative damage and enhanced mitochondrial activity. Furthermore, the expression of inflammatory cytokines, tumor necrosis factor-α, interleukin-6, and monocyte chemoattractant protein-1 were obviously reduced after neutrophil depletion, accompanied with decreased F4/80 mRNA level and macrophage percentage in liver. The decreased NF-κB signaling activity was also involved in the beneficial effect of neutrophil depletion.
Taken together, neutrophil depletion could attenuate metabolic syndromes and hepatic dysfunction.
KeywordsNeutrophil Non-alcoholic fatty liver disease Lipid β-oxidation Mitochondria Inflammation
This study was supported by the National Natural Science Foundation of China (81571395, 81373075 and 81371748).
This study was funded by the National Natural Science Foundation of China (81571395, 81373075 and 81371748).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
Procedures involving the animal experiments were approved by the Wenzhou Medical University Animal Policy and Welfare Committee.
- 4.A. Leroux, G. Ferrere, V. Godie, F. Cailleux, M.L. Renoud, F. Gaudin, S. Naveau, S. Prevot, S. Makhzami, G. Perlemuter, A.M. Cassard-Doulcier, Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. J. Hepatol. 57, 141–149 (2012)CrossRefGoogle Scholar
- 7.M. Donini, S. Fontana, G. Savoldi, W. Vermi, L. Tassone, F. Gentili, E. Zenaro, D. Ferrari, L.D. Notarangelo, F. Porta, F. Facchetti, L.D. Notarangelo, S. Dusi, R. Badolato, G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms. Blood 109, 4716–4723 (2007)CrossRefGoogle Scholar
- 12.R. Ibusuki, H. Uto, S. Arima, S. Mawatari, Y. Setoguchi, Y. Iwashita, S. Hashimoto, T. Maeda, S. Tanoue, S. Kanmura, M. Oketani, A. Ido, H. Tsubouchi, Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, l-amino acid-defined diet. Liver Int. 33, 1549–1556 (2013)PubMedGoogle Scholar
- 14.C. Koliaki, J. Szendroedi, K. Kaul, T. Jelenik, P. Nowotny, F. Jankowiak, C. Herder, M. Carstensen, M. Krausch, W.T. Knoefel, M. Schlensak, M. Roden, Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 21, 739–746 (2015)CrossRefGoogle Scholar
- 16.K.E. Duberley, A.Y. Abramov, A. Chalasani, S.J. Heales, S. Rahman, I.P. Hargreaves, Human neuronal coenzyme Q10 deficiency results in global loss of mitochondrial respiratory chain activity, increased mitochondrial oxidative stress and reversal of ATP synthase activity: implications for pathogenesis and treatment. J. Inherit. Metab. Dis. 36, 63–73 (2013)CrossRefGoogle Scholar
- 22.A. Herms, M. Bosch, B.J. Reddy, N.L. Schieber, A. Fajardo, C. Ruperez, A. Fernandez-Vidal, C. Ferguson, C. Rentero, F. Tebar, C. Enrich, R.G. Parton, S.P. Gross, A. Pol, AMPK activation promotes lipid droplet dispersion on detyrosinated microtubules to increase mitochondrial fatty acid oxidation. Nat. Commun. 6, 7176 (2015)CrossRefGoogle Scholar
- 23.X. Fu, R.M. Chin, L. Vergnes, H. Hwang, G. Deng, Y. Xing, M.Y. Pai, S. Li, L. Ta, F. Fazlollahi, C. Chen, R.M. Prins, M.A. Teitell, D.A. Nathanson, A. Lai, K.F. Faull, M. Jiang, S.G. Clarke, T.F. Cloughesy, T.G. Graeber, D. Braas, H.R. Christofk, M.E. Jung, K. Reue, J. Huang, 2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling. Cell Metab. 22, 508–515 (2015)CrossRefGoogle Scholar
- 27.E. Passos, C.D. Pereira, I.O. Goncalves, S. Rocha-Rodrigues, N. Silva, J.T. Guimaraes, D. Neves, A. Ascensao, J. Magalhaes, M.J. Martins, Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. Life Sci. 123, 51–60 (2015)CrossRefGoogle Scholar
- 28.P. Filipazzi, R. Valenti, V. Huber, L. Pilla, P. Canese, M. Iero, C. Castelli, L. Mariani, G. Parmiani, L. Rivoltini, Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25, 2546–2553 (2007)CrossRefGoogle Scholar
- 33.D.E. Dulek, D.C. Newcomb, K. Goleniewska, J. Cephus, W. Zhou, S. Reiss, S. Toki, F. Ye, R. Zaynagetdinov, T.P. Sherrill, T.S. Blackwell, M.L. Moore, K.L. Boyd, J.K. Kolls, R.S. Peebles Jr., Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner. Infect. Immun. 82, 3723–3739 (2014)CrossRefGoogle Scholar
- 36.A.P. de Vries, P. Ruggenenti, X.Z. Ruan, M. Praga, J.M. Cruzado, I.M. Bajema, V.D. D’Agati, H.J. Lamb, D. Pongrac Barlovic, R. Hojs, M. Abbate, R. Rodriquez, C.E. Mogensen, E. Porrini; Diabesity E-EWG, Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2, 417–426 (2014)CrossRefGoogle Scholar
- 37.L. Martinez-Rubio, S. Morais, O. Evensen, S. Wadsworth, J.G. Vecino, K. Ruohonen, J.G. Bell, D.R. Tocher, Effect of functional feeds on fatty acid and eicosanoid metabolism in liver and head kidney of Atlantic salmon (Salmo salar L.) with experimentally induced heart and skeletal muscle inflammation. Fish Shellfish. Immunol. 34, 1533–1545 (2013)CrossRefGoogle Scholar
- 41.A.B. Santamarina, M. Carvalho-Silva, L.M. Gomes, M.H. Okuda, A.A. Santana, E.L. Streck, M. Seelaender, C.M. Oller do Nascimento, E.B. Ribeiro, F.S. Lira, L.M. Oyama, Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. J. Nutr. Biochem 26, 1348–1356 (2015)CrossRefGoogle Scholar